Discuss the differences between currently approved and emerging biologic treatment options for CRSwNP using data from clinical trials and other analyses

Discuss dietary management and major clinical events associated with LC-FAOD

Describe the latest research being presented to better manage Gaucher disease and it clinical relevance.

Review the role of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition in patients with primary and secondary hyperlipidemia.

Review current and emerging treatment options for patients with PAH and develop strategies to effectively identify side effects and optimize patient outcomes

To provide learners with a comprehensive education on the assessment, diagnosis, and management/support of individuals and families with Pompe Disease, that addresses knowledge and competence gaps to contribute to suboptimal care.  

This activity will review risk factors for hepatocellular carcinoma, guidelines for screening and treatment, and strategies to improve cancer care in rural and underserved areas.